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ABSTRACT Two spin-labeled derivatives of the ion conductive peptide alamethicin were synthesized and used to examine its
binding and state of aggregation. One derivative was spin labeled at the C-terminus and the other, a leucine analogue, was spin
labeled at the N-terminus. In methanol, both the C and N terminal labeled peptides were monomeric. In aqueous solution, the
C-terminal derivative was monomeric at low concentrations, but aggregated at higher concentrations with a critical concentration
of 23 p,M. In the membrane, the C-terminal label was localized to the membrane-aqueous interface using '3C-NMR, and could
assume more than one orientation. The membrane binding of the C-terminal derivative was examined using EPR, and it exhibited a
cooperativity seen previously for native alamethicin. However, this cooperativity was not the result of an aggregation of the peptide
in the membrane. When the spectra of either the C or N-terminal labeled peptide were examined over a wide range of membrane
lipid to peptide ratios, no evidence for aggregation could be found and the peptides remained monomeric under all conditions
examined. Because electrical measurements on this peptide provide strong evidence for an ion-conductive aggregate, the
ion-conductive form of alamethicin likely represents a minor fraction of the total membrane bound peptide.
INTRODUCTION
Small peptide ion channels provide attractive, tractable
systems with which to examine the molecular features of
ion conduction. Among these model systems, alamethi-
cin is a particularly intriguing peptide because it pro-
duces a highly voltage-dependent ion conductance in
planar bilayers (Mueller and Rudin, 1968). Alamethicin
is a 20 amino acid peptide from the fungus Trichoderma
viride. It often is isolated as two components with the
sequence Ac-Aib-Pro-Aib-Ala-Aib-Ala(Aib)-Gln-Aib-
Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu-Gln-Phol,
where one component has Ala and the other Aib at
position 6 (Pandey et al., 1977). The voltage-dependent
ion conduction of alamethicin is accompanied by a
strong concentration dependence and multiple conduc-
tance states (see, for example, Boheim and Kolb, 1978).
These observations are most easily interpreted in terms
of an aggregated state for the peptide ion channel,
where changes in the size of the aggregate account for
the multiple conductance states. Several models have
been advanced to describe the voltage sensitivity and
conduction of this peptide, and in each of these models
the ion conductive state is an aggregate of alamethicin
monomers.
The partitioning of alamethicin between the aqueous
and membrane phases has been examined in phospho-
lipid vesicles using the change in molar ellipticity at 224
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nm that accompanies its binding (Schwarz et al., 1986;
Rizzo et al., 1987; Stankowski and Schwarz, 1989). The
concentration dependence of alamethicin binding indi-
cates that the free energy of binding becomes more
negative as the ratio of peptide to lipid increases. A
logical interpretation of this cooperative behavior, con-
sistent with the proposed structural models, is that the
increase in membrane affinity is a result of the aggrega-
tion of the peptide within the membrane interior. A
thermodynamic treatment, based on this interpretation
of the binding data, was developed and used to study the
state of aggregation of the membrane-bound peptide
(Schwarz et al., 1986).
In this report, the dynamics and state of aggregation
of two spin-labeled derivatives of alamethicin are de-
scribed. One of these spin labels was previously synthe-
sized and contains a proxyl label on the C-terminal
phenylalaninol of alamethicin (Archer and Cafiso, 1989;
Wille et al., 1989). The other is an N-terminally labeled
derivative of a synthetic analogue of alamethicin where
Aib residues are replaced by Leu (Molle et al., 1989).
The spin-labeled alamethicins are used here to charac-
terize the binding of this peptide to the membrane and
to examine the peptide dynamics and state of aggrega-
tion. While the binding data is consistent with that
previously obtained using optical techniques (Schwarz et
al., 1986), the EPR spectra clearly indicate that aggrega-
tion of the membrane-bound peptide cannot account for
the cooperativity seen in the binding data. The work
carried out here has important implications for future
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work directed at elucidating the structure and mecha-
nism of gating of this peptide ion channel. In particular,
structural studies based on spectroscopic approaches
(optical and magnetic resonance) may have difficulty
probing the active form of this peptide.
MATERIALS AND METHODS
Materials
Egg phosphatidylcholine (egg PC) was isolated from fresh hen eggs
according to the procedure of Singleton et al. (1965), and was stored as
a chloroform solution at -20°C under argon. Dioleoylphosphatidylcho-
line (DOPC) was obtained from Avanti Polar Lipids (Birmingham,
AL). The spin-label precursor 3-carboxyproxyl was obtained from
Eastman Kodak (Rochester, NY). Alamethicin was obtained from
Sigma Chemical Co. (St. Louis, MO) and its chemical purity and
sequence was characterized using HPLC and mass spectrometry.
HPLC of alamethicin from Sigma Chemical Co. was carried out on a
C-8 column in acetonitrile/water (0.1%TFA) and separated the
peptide into two components, with component 1 being about twice as
abundant as component 2. Components 1 and 2 had major ion peaks at
an mlz of 1,964 and 1,978, a difference of one methyl unit. Sequencing
of the peptide from the secondary ion fragments showed that position
6 was Ala in component 1 and Aib in component two. Residue 18 of
alamethicin has been reported to contain either Glu or Gln, depending
upon the source (Jung et al., 1981; Rizzo et al., 1987). The alamethicin
used here from Sigma Chemical Co. has Gln at position 18. This was
determined by measuring the masses after rigorous methylation and
was also indicated by the lack of a reaction of residue 18 under
conditions used to spin label the C-terminus. An analogue of alamethi-
cin, I, was obtained from a commercial source (Peptide Technologies,
Washington, DC.) having the sequence Leu-Pro-Leu-Ala-Leu-Ala-Gln-
Leu-Val-Cys-Gly-Leu-Leu-Pro-Val-Leu-Leu-Gln-Gln-Phe-NH2. This
sequence was chosen because it resembles a leucine analogue of
alamethicin that is functionally and structurally similar to alamethicin
(Molle et al., 1988, 1989), and because it has two possible sites for spin
labeling. After receiving the peptide, the molecular weight of the
peptide was confirmed by mass spectrometry, which yield primary ions
at mle 2,149 for MH+ ion and 2,132 for MH+-NH3 ion.
Synthesis of a C-terminal spin
labeled alamethicin analogue
The C-terminal spin labeled analogue of alamethicin, C-ala, was
produced using a procedure similar to one described previously by
coupling 3-carboxyproxyl to the C-terminal phenylalaninol of alamethi-
cin usingN, N-dicyclohexylcarbodiimide (DCC) and dimethylaminopy-
ridine (Wille et al., 1989). The spin-labeled product, which was
purified by flash chromatography in silica gel in chloroform/methanol
(80:20), yielded a mass spectrum with major primary ions at mie values
of 2,133 and 2,147. These corresponded to the MH+ ions for proxyl
attached to component 1 and component 2, respectively. Fragment
ions were used to further confirm the product, and the following
C-terminal B ions from fragmentation at Prol4 were prominent in the
spectrum: B,6Y7 (282), B17Y7 (367), B18Y7 (495), B,9Y7 (623) and
Y7-proxyl (942). This nomenclature follows that outlined previously for
single and multipoint fragmentation of the peptide backbone where
B16Y7 represents P-V-a, B17Y7 represents P-V-a-a, etc. (Hunt et al.,
1986). The absence of the following ions: B,8Y7-proxyl (663), B19Y7-
proxyl (791) and Y7 (774), indicates that the label is attached to the
C-terminal Phol residue.
Synthesis of an N-terminal spin
labeled leucine alamethicin analogue
An N-terminal spin-label of the leucine alamethicin analogue, I, was
produced by first blocking the CyslO residue with maleimide to
produce a product referred to here as II. II was then reacted at the
N-terminus with a symmetric spin-labeled anhydride to produce the
spin-labeled product (this peptide label will be referred to as N-leu-
ala). To produce II, Cys10 was blocked with maleimide by dissolving
10.5 mg of I in methanol followed by addition of a solution of
N-ethylmaleimide (5.4 mg in 40 ILL methanol plus 2 mL sodium
acetate buffer pH 4.5). The reaction mixture was stirred at 40°C for 1.5
h and monitored by TLC on silica gel G plates (Analtech, Newark,
DE) in CHCl3/MeOH/H20 (65:25:4). In this eluent, the Rf of the
product II was 0.48. The reaction mixture was then subjected to rotary
evaporation and lyophilized to remove solvent and buffer. A 5,5'-
dithiobis(2-nitrobenzoic acid) (DTNB) test of the lyophilized product
II indicated that there were no free sulfhydryls. II was purified on silica
gel 60 (70-230 mesh ASTM; EM Science, Cherry Hill, NJ) eluted with
CHCl3/MeOH (75:25) and then CHCl3/MeOH/H20 (65:25:4). The
fractions containing II were subjected to rotary evaporation and
lyophilized to yield a white powder. The product was confirmed by
mass spectrometry which yielded the primary ions MH+ at 2,274 and
MNa+ at 2,297. The symmetric anhydride of 3-carboxyproxyl was
produced by dissolving 11.8 mg of 3-carboxyproxyl in 0.1 mL DMF
(peptide synthesis grade) along with 120 F.L of a 0.275-M solution of
DCC in dichloromethane. The mixture was stirred for 1 h and then
filtered to remove insoluble dicyclohexyl urea. The symmetric anhy-
dride solution was added to a solution of 11 (6.6 mg) dissolved in 1 mL
DMF. The reaction mixture was stirred for 1 h and monitored by TLC
on silica gel G plates in CHCl3/MeOH/H20 (65:25:4). In this eluent,
the product had an Rf of 0.67. The DMF was removed by repeated
additions of water followed by lyophilization. The product was purified
on a column of silica gel (EM Science) run with CHCl3IMeOH/H20
(65:25:4), and then rotary evaporated and lyophilized from water to
yield a white powder. The product, N-leu-ala, was confirmed by mass
spectrometry which yielded major ions at an mie of 2,444, 2,428, and
2,466 corresponding to the primary ions MH+, MH+-H20, and MNa+.
Preparation of lipid vesicles
Sonicated lipid vesicles were prepared by drying aliquots of lipid under
vacuum for periods of at least 15 h, hydrating the lipid in the
appropriate buffer solution, and ultrasonically irradiating the sample
at 0°C under argon as previously described (Castle and Hubbell, 1976).
To prepare larger "extruded" vesicles, the vortexed lipid suspension
was freeze-thawed five times, and then extruded 10 times through 0.05
,uM polycarbonate filters using a commercially available unit (Lipex
Biomembranes Inc., Vancouver, B.C.). After the final extrusion, the
phospholipid vesicles were stored at 4°C under an argon atmosphere
until use. Final lipid concentrations were determined using a modified
Fiske-Subbarrow phosphate assay (Bartlett, 1959). Sonicated vesicles
were sized using both "4C sucrose (Cafiso and Hubbell, 1978) and a
spin probe assay (Todd et al., 1989). Both sizing techniques indicated
that the average diameter of the sonicated vesicles was 220 + 30 A.
The extruded vesicles had an average diameter of 400 + 50 A as
determined using the spin probe assay.
EPR spectroscopy
EPR spectroscopy was carried out using either a Varian (Sunnyvale,
CA) E-line Century Series or a modified V-4500 series X-band
spectrometer. A 100-pLl quartz sample cell was used to hold the
sample. EPR spectra were obtained with a modulation amplitude of
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1.0 G and a power of 10 mW. Spectra used for the determination of
rotational correlation times T, were taken with modulation amplitudes
in the range of 0.2-0.4 G. Processing and manipulation of the EPR
spectra were carried out on an IBM compatible personal computer
using the software package "EPR Data Acquisition System, Version
2.2" (Philip D. Morse, II and the University of Illinois College of
Medicine, Urbana, IL). The klystron frequency was determined using
a Hewlett Packard X532B frequency meter and the magnetic field
strength was measured using an 'H NMR gauss meter.
To measure the binding of spin-labeled alamethicin to phospholipid
vesicles, a special quartz sample cell was used that allowed additions of
peptide or lipid to the sample without removal of the cell from the
EPR cavity. The binding of the peptide to the membrane was
determined from the EPR spectrum by measuring the amplitude of the
high field nitroxide resonance in a manner identical to that used
previously for nitroxide probes (see Castle and Hubbell, 1976). The
partitioning of the probe can be expressed as the ratio of the number of
spins bound to the membrane to the number of spins in solution, Nb/Nf
or X. The binding data was then analyzed and expressed using two
different approaches. In one, the measurable parameter X was related
to a partition coefficient having units of length. In this case, 1/c, =
PAI(1/X) + V,, where c, is the lipid concentration, AI is the average
lipid surface area (5.16 x 106 cM2/g lipid for sonicated vesicles) and V,
is the specific volume of the lipid (see Flewelling and Hubbell, 1986).
In another approach, the molar ratio, r, of lipid associated peptide to
lipid (r = cb/c,) was plotted as a function of the free peptide concentra-
tion, a representation used previously to illustrate the cooperative
binding of alamethicin (Schwarz et al., 1986).
Spectra of oriented bilayers were obtained from stacks of hydrated
lipid bilayers on glass slides. To form these layers, spin-labeled peptide
(0.05-0.10 mol%) and/or 5-doxylstearate (0.2 mol%) was added to a
solution of lipid (3.2 mg egg PC in 125 LL of chloroform). One drop
of this mixture was applied to each glass slide (9.9 x 12 mm). The
lipid-coated slides were dried for 2-3 h in a vacuum desiccator. The
slides were then sealed in an argon/water saturated chamber for at
least 24 h to allow the lipid layers to hydrate. After hydration, 10-12
lipid-coated slides were stacked and pressed together. The stack of
slides was secured in a teflon holder that could be rotated in the EPR
cavity. To ensure that the system used here produced oriented
bilayers, spectra of 5-doxylstearate were obtained and compared with
previous data on oriented nitroxides (see, for example, Gaffney and
McConnell, 1974).
Determining the membrane location
of peptide associated spin labels
The location of the nitroxide label attached to the C-terminus of
alamethicin was determined by investigating the effect of the nitroxide
on the 13C spin-lattice relaxation rate of the membrane lipid. This was
carried out in a manner similar to that used previously to localize
paramagnetic hydrophobic ions (Ellena et al., 1988). NMR spectros-
copy was performed on a General Electric GN 300 NMR spectrometer
operating at a proton frequency of 300.53 MHz and a carbon-13
frequency of 75.57 MHz. A sample size of 0.5 mL was used in a 5-mm
NMR tube, with a sample temperature of 28 ± 1°C. 13C spin-lattice
relaxation rates (Tl') were measured using a fast inversion recovery
experiment, and all 1800 pulses were 90x, 180y, 90x composite pulses.
'H decoupling was used throughout the experiment. The membrane
samples contained 130mM lipid sonicated in 25mM phosphate buffer,
pD 7.4. To these samples either 3 mol% spin-labeled alamethicin or
native alamethicin (as a control) were added.
Determining rotational correlation
times from EPR spectra
The rotational mobility of the nitroxide probes was quantitatively
determined from the transverse relaxation rates measured from EPR
spectra using procedures similar to those described previously (Keith
et al., 1970; Nordio, 1976). Here, the rotational correlation time, T,,
was expressed in terms of the following relationship:
b 48 15 T2(0) 0)
where Ho is the strength of the magnetic field, T2(0) and T2(-1) are
the transverse relaxation times of the m, = 0 and m, = -1 nitroxide
resonances, b = 47r/3[A - '/2(A,, + A,,)], and A&y = (J1)[g. -
1/2(g. + gy)]. The transverse relaxation time T2(0) was taken from the
linewidth of the EPR spectrum, and the ratio of the T2 values was
taken from the relative peak height intensities. Solution spectra were
used to measureA., the isotropic hyperfine coupling constant.A. was
determined from the spectra of samples frozen in liquid nitrogen,
77°K. Under these conditions, Azz is equal to Am., and these values
were then used to calculate A,.. A,, (which are assumed to be equal).
The g values for 3-carboxyproxyl were taken from previously reported
values (Bordeaux et al., 1973) and were corrected for differences in go
values after a method described previously (Snipes et al., 1974). The
g-values used were g,, = 2.0089, g,, = 2.0055, g,, 2.0030. It should be
noted that this calculation of;,, assumes isotropic motion of the spin
label.
Determining the activity of
alamethicin derivatives in vesicles
The activity of both the spin labeled alamethicin analogues used here
was tested in vesicle systems using procedures that are described in
detail elsewhere (Archer and Cafiso, 1991). In these measurements,
current-voltage curves for the peptides were obtained by establishing
voltages in vesicles and monitoring the current flow through the
alamethicin channel with potential sensitive nitroxide probes. Volt-
ages were established across extruded lipid vesicles by creating a
proton or K+ electrochemical equilibrium. The current flow through
the alamethicin channel was monitored using a nitroxide probe
sensitive to the proton gradient, while protons were maintained in an
electrochemical equilibrium with a protonophore. The spin-labeled
peptides did not interfere with the signal from the probe nitroxides.
Under the conditions of these measurements, the spin-labeled pep-
tides were membrane bound and the amplitude of the high-field
resonance (which was used to monitor the pH probe) was dominated
by the aqueous pH probe signal.
RESULTS
Dynamics and aggregation of
spin-labeled alamethicin in aqueous
solution
Shown in Table 1 are the spectral parameters obtained
for the C-terminal proxyl derivative of alamethicin
(C-ala) and 3-carboxyproxyl. These values were used
along with an estimate of the transverse relaxation rate
to estimate the correlation time, 'r, for the probe
attached to C-ala (see Methods). This calculation yielded
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TABLE 1 The buffer solution used In these experiments
contained 125 mM K2SO4,25 mM MOPS, pH = 7.0
Label AO All= A0,A,
3-carboxyproxyl in buffer 16.26 ± 0.01 36.13 ± 0.6 6.33 ± 0.04
C-ala in buffer 15.98 ± 0.03 36.27 ± 0.06 5.84 ± 0.05
3-carboxyproxyl in
methanol 15.26 ± 0.02 36.19 ± 0.06 4.8 ± 0.04
C-ala in methanol 15.13 ± 0.02 36.28 ± 0.06 4.56 ± 0.04
C-ala in eggPC 35.64 ± 0.06
Measurements in sonicated lipid vesicles were carried out at a lipid
concentration of 85 mg/ml.
a correlation time of 0.22 ns in a buffered aqueous
solution at pH = 7. This value agrees with the value
obtained previously for this derivative (0.28 ns) in water
using a similar procedure (Wille et al., 1989), but is
shorter than the values obtained for the proline protons
of the peptide in methanol (0.4-0.7 ns) using NMR
spectroscopy (Banerjee et al., 1983; Esposito et al.,
1987). Because the proline protons reflect backbone
motion, this lower correlation time likely reflects an
additional segmental motion of the proxyl moiety. Mea-
surements in methanol for C-ala yielded a correlation
time of 0.12 ns, and the ratio of correlation times
(methanol/water) is 0.55, which agrees well with the
ratio of viscosities for these solutions of 0.60. Because
the peptide is monomeric in methanol (McMullen and
Stirrup, 1971; Esposito et al., 1987), this agreement
indicates that the peptide is also monomeric at an
aqueous concentration of 15 ,uM.
In methanol, spin-labeled analogues of alamethicin
yielded signal intensities that were completely linear
with concentration (5-100 p,M), and showed no indica-
tion of aggregation. However, in aqueous solution,
aggregation at low peptide concentrations was apparent.
Fig. 1 shows the dependence of the intensity of the
center field resonance (mi = 0) as a function of the
concentration of the labeled peptide C-ala. At low
concentrations of C-ala, the amplitude of the EPR
spectrum in aqueous solution increases linearly with the
concentration of peptide; however, above 20 p,M pep-
tide the signal amplitude reaches a maximum and
becomes independent of the peptide concentration.! At
very high concentrations of peptide, an EPR spectrum
'In the absence of lipid, the signal intensity from spin-labeled
alamethicin increased linearly with the concentration of peptide up to
-20 IuM, but did not intersect the concentration axis at zero. The
simplest interpretation of this observation is that the hydrophobic
peptide binds to some portion of our mixing apparatus or EPR cell.
This was a small effect that corresponded to the absorption of few tens
of pmoles of peptide. The absorption of alamethicin to teflon cells
used for planar bilayer studies has also been observed (Stankowski et
al., 1988).
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FIGURE 1 Signal intensity of the m, = 0 resonance for the C-terminal
spin-labeled alamethicin, C-ala, in aqueous solution as a function of
the alamethicin concentration. For the linear portion of the curve
alamethicin is monomeric, but undergoes a micellization at a critical
concentration of -23 ,uM. The aqueous sample contains 125 mM
K2SO4, 25 mM MOPS, pH = 7.
taken at liquid nitrogen temperatures reveals clear
evidence for spin exchange. These observations are
consistent with an aggregation or micellization of the
peptide, a process that was previously observed using
hydrodynamic techniques (McMullen and Stirrup, 1971)
or fluorescent fragments of alamethicin (Mathew et al.,
1981). From the data shown in Fig. 1, a critical concen-
tration of 23 pM is obtained for the aqueous micelliza-
tion of C-ala.
The N-terminal label of the alamethicin derivative,
N-leu-ala, is a much more hydrophobic peptide than
native alamethicin and it was not soluble in aqueous
solution at levels that would allow detection by EPR
(greater than 1 ,uM). However, this derivative was
soluble in methanol and yielded a correlation time of 0.3
ns, which is about twice that obtained for the C-terminal
proxyl nitroxide. This reduction in motional rates could
reflect the additional double bound character in the
peptide-label linkage, or the greater helical content of
the N-terminal domain of the peptide (Esposito et al.,
1987).
Both spin-labeled analogues yield
nonlinear current voltage curves
Using procedures described elsewhere, the ion conduc-
tive properties of the spin-labeled peptides were tested
in vesicles, under conditions where all the peptide was
membrane bound. Shown in Fig. 2 are current voltage
data for both C-ala and N-leu-ala. Because these experi-
ments were carried out under two different sets of
conditions, two different y axes are used. The activity
obtained for C-ala and N-leu-ala are comparable to the
activity obtained for native alamethicin under each of
39 ipyia ora uut19
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FIGURE 2 Current voltage-curves for C-ala (0 and left y-axis) and
N-leu-ala (A and righty-axis) in extruded 400 A lipid vesicles. For the
case of N-leu-ala, the membrane potentials were established using a
pH gradient. In the case of C-ala, K+ gradients were used to establish
the membrane potentials. As a result, the absolute magnitude of the
currents are not directly comparable. However, these currents are
similar to those obtained for native alamethicin under each experimen-
tal arrangement. In each case, protons are maintained in an electro-
chemical equilibrium and the currents are monitored using a ApH-
dependent paramagnetic probe as described elsewhere (for more
details see Archer and Cafiso, 1991).
these conditions (see Archer and Cafiso, 1991). This
data indicates that in spite of the attachment of the
proxyl group to these derivatives, their ion conductive
behavior has not been significantly altered.
Dynamics of spin-labeled alamethicin
in lipid bilayers
Shown in Figs. 3, a and b, are the EPR spectra of C-ala
and N-leu-ala, respectively, in lipid vesicles of egg PC.
As expected, the C-ala derivative exhibits less mobility
FIGURE 3 (A) EPR spectra for the C-terminal spin labeled alamethi-
cin analogue, C-ala. This peptide is at a concentration of 15 p.M in the
presence of sonicated eggPC vesicles at a lipid concentration of 40
mg/ml. At this concentration of lipid the peptide is totally membrane
associated. (B) EPR spectrum for the N-terminal spin labeled leucine
alamethicin analogue, N-leu-ala. This labeled peptide is at a concentra-
tion of 20 p,M in eggPC vesicles at a lipid concentration of 140 mg/ml.
In both A and B, the aqueous buffer contains 125 mM K2S04 and 25
mM MOPS, pH = 7.
than in aqueous solution. The apparent correlation time
estimated from this spectrum is 3 ns. To provide some
insight into the nature of the C-ala motion, EPR spectra
for this spin-labeled derivative were obtained in ori-
ented lipid bilayers. Shown in Figs 4, a and b are the Ho 11
z' and Ho I z' spectra for C-ala in oriented eggPC
bilayers, respectively. In each orientation, the spectrum
exhibited at least two components which were most
easily distinguished in the Ho 11 z spectrum. A control
experiment was performed where the oriented sample
was prepared in the same manner except that native
alamethicin was incorporated along with 1 mol% 5-doxyl
stearate. The spectra that were obtained from this
control sample for the Ho 11 z' and Ho I z' orientations
indicate that the bilayers are highly oriented (Gaffney
and McConnell, 1974) and that poor bilayer alignment is
not an explanation for the spectra in Fig. 4.
The location of the nitroxide of C-ala in the mem-
brane was determined by examining its effect on the 13C
relaxation rates of the membrane lipid (see Methods).
The enhancement in the relaxation rate obtained for the
lipid carbons in the presence of labeled vs. unlabeled
alamethicin is shown in Fig. 5. The enhancement in the
relaxation rate is dominated by proximity between the
label and the lipid carbons (Ellena et al., 1988) and the
data shown here is consistent with an interfacial location
for the C-terminus of C-ala.
Phase partitioning and cooperative
binding of spin-labeled alamethicin
Shown in Fig. 6 is a spectrum of C-ala in solution and in
the presence of membrane vesicles at concentration of
0.15 mg/ml. In the presence of vesicles, the spectrum is a
composite of two spectra, one that clearly arises from an
aqueous population, and one that is identical to the
membrane-bound spectrum. As described above (see
A
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FIGURE 4 (A) An EPR spectrum of spin-labeled alamethicin in
oriented eggPC bilayers at a concentration of 0.1 mol%. This spectrum
was acquired with the magnetic field oriented parallel to the bilayer
normal, z'. Two components (marked) are visible in this oriented
spectrum (B) An EPR spectrum of the sample in A, except that the
magnetic field is now oriented perpendicular to the magnetic field.
Archer et aS. Spin-Labeled Alamethicin
vlJ WXs
Archer et al. Spin-Labeled Alamethicin 393
1.5 [
0.5
n 0I 3 T 44
, ~ ~~~~~~~~
9.
9
I
2
A
.Lor.
20 40 60
1/conc
0.31
09 In
0,
Lipid Carbon
FIGURE 5 A plot showing the enhancement of the 13C relaxation
rates for various membrane lipid resonances in the presence of the
C-terminal labeled alamethicin analogue. The membrane lipid is
eggPC and the values of 1/T,P, represent the difference in the
relaxation rate between membranes containing 3 mol% spin-labeled
alamethicin and membranes containing 3 mol% unlabeled alamethi-
cin.
Fig. 1) the signal intensity of the peptide resonance from
solution is linear up to 15 p,M, and the concentration of
peptide in the partitioning experiments did not exceed
this level. From the amplitude of the high-field reso-
nance of spectra for C-ala, the membrane-aqueous
phase partitioning for the peptide was determined (see
Methods). Shown in Fig. 7 a is a binding curve for C-ala
in sonicated eggPC vesicles. In this plot, the slope is
constant up to 300 peptides/vesicle (10 lipids/peptide)
and then increases. This increase represents a decrease
(or saturation) of the binding above this peptide concen-
tration. From the linear portion of the curve, a partition
lOgauss
FIGURE 6 An EPR spectrum of the C-terminal labeled alamethicin at
a concentration of 14 F.M in the presence of sonicated eggPC vesicles
(0.15 mg/ml lipid in 125 mM K2SO4, 25 mM MOPS, pH = 7). This
spectrum is a composite of two spectra arising from both aqueous and
a membrane associated peptide. It is qualitatively similar to spectra
obtained previously for amphiphilic nitroxides. The phase partitioning
of this peptide is quantitated from the amplitude of the high-field
nitroxide resonance, A, using procedures described elsewhere (Castle
and Hubbell, 1976).
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FIGURE 7 (A) Binding curve for the C-terminal labeled alamethicin
in the presence of sonicated egg PC vesicles. The ratio of the aqueous
to bound peptide populations (1/X) is plotted as a function of the
reciprocal of the lipid concentration in milliliters per milligrams. For
the linear portion of this binding curve, the slope is fit well with a value
for the partition coefficient ,B of 0.017 cm. In this experiment the total
concentration of the C-terminal label is 11.4 ,uM and the buffer
contains 125 mM K2S04, 25 mM MOPS, pH = 7. (B) A binding curve
for the C-terminal labeled alamethicin derivative (13.8 ,uM) in the
presence of egg PC (0) and DOPC (A). Here the bound peptide/lipid
is plotted vs. the free peptide concentration in a fashion identical to
that used previously (Schwarz et al., 1986). The cooperativity seen
previously for native alamethicin is also apparent here for the
C-terminal spin-labeled alamethicin derivative. The data for DOPC is
made in 10 mM tris-HCL, pH = 7.3 for a comparison with data on
unlabeled alamethicin.
coefficient, 3, of 0.017 cm is obtained. If the peptide
occupied the entire membrane volume, this partition
coefficient would correspond to a free energy of binding
of -6.2 Kcal/mol. The data for the binding of C-ala to
eggPC and dioleoylphosphatidylcholine (DOPC), is plot-
ted in Fig. 7 b as the ratio of peptide to lipid vs. the total
peptide concentration. Plotted in this fashion, the satu-
ration of binding appears as a decrease in slope above 2
FiM aqueous peptide. The data for DOPC in Fig. 7 b is
clearly different than that seen for egg PC, and shows a
cooperativity in binding at low concentrations (< 1 ,uM)
that was seen previously for native alamethicin in lipid
vesicles (Schwarz et al., 1986).
The binding curves obtained previously for native
alamethicin are similar to those shown here (Fig. 7 b).
The cooperativity that appears in this binding curve was
previously interpreted in terms of an aggregation of the
membrane bound peptide. From the sharp upward turn
in this curve at low concentrations, an apparent "critical"
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concentration for the aggregation of alamethicin in the
membrane can be determined. Above the critical concen-
tration, a majority of the membrane-bound alamethicin
is expected to exist in an aggregated state. For C-ala, this
critical concentration is 0.8 p,M in DOPC. This is less
than the 2.1 p,M critical concentration reported for
native alamethicin in this lipid; however, this could be a
result of different experimental conditions. The critical
concentration was shown previously to be sensitive to
ionic strength and lipid saturation (Stankowski et al.,
1988).
To test the idea that cooperativity in the binding is
due to aggregation, EPR spectra were obtained for
C-ala in lipid vesicles both below and above this critical
alamethicin concentration. When the concentration of
membrane bound C-ala was increased, changes in the
spectrum at high peptide to lipid ratios were observed;
however, these changes were not observed except at high
concentrations where exchange broadening is normally
seen (Scandella et al., 1972). The two spectra shown in
Fig. 8 provide a more critical test for aggregation. Here
the concentrations of C-ala are identical (i.e., the
membrane concentration of spin are the same), but the
ratio of lipid to peptide is varied from 100:1 to 5:1 by
changing the level of unlabeled alamethicin. The spec-
tral lineshapes for these two peptide concentrations
(Fig. 8) are virtually identical; in addition, the intensities
of the centerfield peak (mi = 0) differed by only 4%, a
difference that is at the level of our experimental
uncertainty. Therefore there is no evidence for the
aggregation of alamethicin even at concentrations well
above the "critical" concentration. Although it was not
possible to observe the partitioning of N-leu-ala, or
determine its critical concentration, the spectra ofN-leu-
ala were examined at very high and low membrane
lipid:peptide
10 gauss
FIGURE 8 (A) An EPR spectrum of 10 ,uM C-terminal labeled
alamethicin in sonicated eggPC vesicles at a lipid to peptide ratio 100.
(B) An EPR spectrum of 10 I1M C-terminal labeled alamethicin plus
190 ILM unlabeled alamethicin to yield a total lipid to peptide ratio of
5. For each case,A and B, the lipid concentration is 0.8 mg/ml and the
buffer is 125 mM K2S04, 25 mM MOPS, pH = 7. If the cooperative
binding of alamethicin is a result of the membrane aggregation of
alamethicin, then the spectra in A and B, should represent primarily
monomeric and highly aggregated peptide.
peptide concentrations. Again the unlabeled analogue
of N-leu-ala was used to vary the membrane concentra-
tion of peptide to avoid the effects of spin exchange. As
was the case for C-ala, the spectra for N-leu-ala at
dramatically different concentrations are virtually identi-
cal and provide no sign of aggregation (data not shown).
From the Saffnan-Delbruck theory of rotational diffu-
sion in membranes, it can be shown that the ratio of
expected rotational correlation times for alamethicin
monomers, dimers, and tetramers is approximately 1:2:4
(Saffnan and Delbruck, 1975). Because the EPR spec-
tra will show a clear change in lineshapes for a twofold
increase in correlation time, the above data indicates
that the aggregation state of the alamethicin analogues
examined here does not change over a concentration
range where changes in the free energy of binding for
alamethicin are seen. Thus, the data shown here do not
support a model where binding "cooperativity" is due to
peptide aggregation.
DISCUSSION
Two alamethicin spin labels were synthesized and used
to examine the state of aggregation of the membrane
bound peptide. The C-terminal proxyl derivative that
was used here was synthesized previously (Archer and
Cafiso, 1989; Wille et al., 1989) and was previously
shown to be similar in its activity to native alamethicin in
planar bilayer systems (Wille et al., 1989). The data
presented in Fig. 2 demonstrates that this analogue is
also active in extruded vesicle systems and is similar in its
activity to that of native alamethicin in these same
membrane systems (Archer and Cafiso, 1991). The EPR
spectrum of this labeled peptide is sensitive to its state of
aggregation in aqueous solution. Using EPR, a value of
23 ,uM for the critical micellization of alamethicin was
obtained, which is in the range of values found for
alamethicin fragments (Mathew et al., 1981). An N-ter-
minal label of an alamethicin analogue, where the Aib
residues are replaced by leucine, was also synthesized.
This analogue was chosen because it was previously
shown to be an active non Aib-containing analogue with
a similar structure to native alamethicin (Molle et al.,
1989). The data obtained here (Fig. 2) also demon-
strates that this spin-labeled analogue has an ion chan-
nel activity in extruded vesicles. When the phase parti-
tioning of C-ala is compared with that for native
alamethicin using optical techniques (Stankowski and
Schwarz, 1989), similar partition coefficients are ob-
tained. Thus, in spite of the addition of a proxyl moiety
to either the C- or N-terminus, the labeled peptides used
here appear to behave in a similar manner to their
unlabeled counterparts. Not surprisingly, the N-termi-
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nal leucine analogue appears to be substantially more
hydrophobic than native alamethicin and has a minimal
solubility in water.
The binding data shown in Fig. 7 b shows a cooperativ-
ity for the binding of C-ala that was seen previously for
alamethicin in DOPC (Schwarz et al., 1986). The bind-
ing of alamethicin increases as the level of membrane-
associated peptide increases until a saturation is reached
at very high peptide concentrations. Because the active
form of alamethicin appears to be an aggregate, a logical
explanation for the cooperativity is the conversion of
monomeric alamethicin into an aggregated form. An
elegant thermodynamic model based on this interpreta-
tion was developed and demonstrated that membrane
aggregation at a critical concentration of 2.5 p,M (in
DOPC) could explain this binding behavior (Schwarz et
al., 1986). A similar binding behavior was observed here
for the proxyl labeled C-ala, and provided a unique
opportunity to test this model. When EPR spectra for
this probe were examined under conditions where the
peptide should have been highly aggregated (according
to this thermodynamic model), there was no evidence
for the transition of alamethicin to an aggregated form.
Because of its low aqueous solubility, a critical concentra-
tion for the N-terminal analogue could not be estab-
lished; however, it also showed no evidence for conver-
sion to an aggregated state when the lipid to peptide
ratios were varied over a wide range. Thus, the mem-
brane aggregation of alamethicin cannot account for the
cooperative binding of alamethicin to membranes.
The membrane-bound form of the spin-labeled alame-
thicin analogues giving rise to the spectra shown here is
almost certainly monomeric. Conceivably, the C- or
N-terminal derivatives could exist in an aggregated form
independent of the concentration of membrane bound
peptide. This is not likely for at least two reasons. First,
dilution of the labeled peptides with unlabeled ana-
logues should have changed the line shape of the
spectrum. Aggregation of the labeled peptide would
have produced strong spin-exchange effects that would
be dramatically reduced by dilution of the labeled
peptide with the unlabeled analogue. Second, the line
shapes that were obtained are not consistent with those
expected for large aggregates. Thus, the membrane
bound form of either of the spin-labeled analogues of
alamethicin appears to remain monomeric under a wide
range of concentrations examined here.
This surprising result raises several important ques-
tions. First, there is strong evidence from electrical
measurements that the active form of alamethicin is a
membrane-bound aggregate having as many as 10 mono-
mers. However, the experiments carried out here failed
to detect evidence for an aggregated form of the
peptide. Assuming that the active form of alamethicin is
indeed an aggregate, this observation indicates that the
active form is only a minor fraction of the total mem-
brane-associated peptide. This conclusion has important
consequences for spectroscopic measurements (optical
or magnetic resonance) aimed at studying the active
form of alamethicin. For example, without procedures
to enhance the population of the aggregated state, it will
be extremely difficult to gain structural information on
active state of alamethicin using spectroscopy. Presently,
electrical measurements appear to be the only way to
monitor the active state of this peptide.
Another intriguing question concerns the physical
interactions that lead to the cooperative binding of
alamethicin. The binding free energy of alamethicin to
DOPC varies from -5.2 to -6 Kcal/mol below and
above the inflection at 1 ,uM peptide (see Fig. 7 b). This
modest energy difference of 0.8 Kcal/mol could be the
result of any number of steric, electrostatic, or enthalpic
peptide-lipid interactions. Indeed, structural changes in
the lipid headgroup appear to accompany the binding of
alamethicin (Banerjee et al., 1985). Such structural
changes could alter the free energy of the membrane-
bound peptide and lead to the observed cooperativity.
Currently, experiments are underway to determine the
source of the cooperativity in the binding.
Several observations regarding the behavior of the
membrane-bound label deserve comment. The N-termi-
nal label has a longer apparent correlation time than the
C-terminal label. This could be a result of an additional
motional restriction in the amide segment which joins
the N-terminal label, or it could reflect the higher helical
content believed to be present in the N-terminal portion
of alamethicin (see, for example, Esposito et al., 1987).
However, since the orientational dependence of this
label is not yet characterized, the apparent difference in
correlation time could simply reflect a difference in the
orientation of the principal hyperfine tensor compo-
nents relative to the axes of motional averaging for this
molecule. Further work on this and other alamethicin
derivatives is addressing these questions. The fact that
there is a clear difference between the oriented spectra
for C-ala (Figs. 4, a and b) indicates that a major fraction
(and perhaps all) of the labeled peptide undergoes
anisotropic motion. The presence of at least two compo-
nents in the oriented spectra indicate that two or more
distinct average orientations exist for the nitroxide label
on this peptide. Because segmental motion about the
ester linkage that attaches the label to the C-terminus
should be very rapid on the EPR time scale, conforma-
tions about this segment are not expected to produce
distinct populations in the spectra. Hence, the popula-
tions seen in Figs. 4, a and b are likely the result of
different orientations for the peptide (or portions of the
peptide) and not simply different label orientations. The
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Ho I z' spectrum exhibits the larger outer splitting;
therefore, the population giving rise to these outer
extrema must have the average position of the nitroxide
z axis aligned closer to the plane of the bilayer rather
than to the bilayer director axis.
The use of 13C-NMR to localize the nitroxide group in
bilayers has been previously reported (Brulet and Mc-
Connell, 1975; Godici and Landsberger, 1974; Ellena et
al., 1988). The measurements made here indicate that
the C-terminus of alamethicin is near the membrane
interface and demonstrate the feasibility of using this
approach to obtain structural information on membrane-
bound peptides. The use of this method is now being
employed to provide further information on the struc-
ture and orientation of membrane-bound alamethicin.
In conclusion, two spin-labeled analogues of alamethi-
cin were synthesized and EPR spectroscopy was used to
examine the aggregation state and binding of alamethi-
cin to membranes. The experiments carried out here
indicate that the cooperative binding seen for alamethi-
cin to lipid vesicles is not the result of a membrane
aggregation of the peptide. No evidence for the aggrega-
tion of this peptide in the membrane could be found,
and alamethicin appears to remain monomeric even at
very high protein to lipid ratios. This observation indi-
cates that the active, aggregated form of the peptide
represents a very minor fraction of the total alamethicin.
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